This article is part of the supplement: International Society on Brain and Behaviour: 2nd International Congress on Brain and Behaviour . Oral presentationAntipsychotic drugs and metabolic disordersAtherosclerosis and Metabolic Syndrome Units, 2nd Prop. Clinic of Internal Medicine Aristotle University of Thessaloniki, Greece
from International Society on Brain and Behaviour: 2nd International Congress on Brain and Behaviour Annals of General Psychiatry 2006, 5(Suppl 1):S9doi:10.1186/1744-859X-5-S1-S9
First paragraph (this article has no abstract)NCEP-ATP III: The Metabolic Syndrome: Diagnosis is established when at least 3 of these risk factors are present |




on Google Scholar







corresponding author email